|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/20 | (2006.01) |
| C12N 9/20 | (2013.01) | ||
| C07K2319/31 | (2013.01) | ||
| C07K2319/35 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| C07K 14/47 | (2013.01) | ||
| C07K 14/605 | (2013.01) | ||
| C07K 14/705 | (2013.01) | ||
| C07K 14/7155 | (2013.01) | ||
| C07K 16/2875 | (2013.01) | ||
| C12N 15/62 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/94 | (2013.01) |
| (11) | Number of the document | 3642338 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18717624.3 |
| Date of filing the European patent application | 2018-04-16 | |
| (97) | Date of publication of the European application | 2020-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/059677 |
| Date | 2018-04-16 |
| (87) | Number | WO 2018/233895 |
| Date | 2018-12-27 |
| (30) | Number | Date | Country code |
| 17176543 | 2017-06-19 | EP |
| (72) |
NILSSON, Joakim , SE
NORDLING, Erik , SE
SVENSSON GELIUS, Stefan , SE
|
| (73) |
Swedish Orphan Biovitrum AB (publ) ,
112 76 Stockholm,
SE
|
| (54) | FUSION PROTEIN WITH HALF-LIFE EXTENDING POLYPEPTIDE |
| FUSION PROTEIN WITH HALF-LIFE EXTENDING POLYPEPTIDE |